본문 바로가기
KERD
논문KCI 등재

생약제제의 약물동태 연구 및 상호작용

Pharmacokinetic Studies and Drug-drug Interactions of Herbal Medicine

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류약학

초록

Drugs mostly represent an efficacy or an adverse effect according to their dosage and/or plasma concentrations. Therefore,to investigate the pharmacokinetic behavior of drugs including herbal medicines is necessary both to maximize the drug action and to minimize the adverse effect. To date, pharmacokinetic studies of herbal medicines have been conducted by some experts in this field on the bases of science and knowledge in Korea. On the other hand, in advanced countries, a typical series of pharmacokinetic studies has been conducted by using a harmonized guidance established. Consequently, an administrative support on these studies has to be needed in Korea as well. This study aimed to establish a draft guidance on pharmacokinetic studies of herbal medicines in non-clinical and clinical studies. Literatures previously published as well as guidances in the US, Europe and Japan were summarized for the present guidance. Effect of herbal medicines was listed on the proteins in charge of drug metabolism and transportation, as well as on the pharmacokinetics of chemical drugs. The present suggestion might be helpful to proceed pharmacokinetic studies of herbal medicines efficiently, and further polish should be needed in terms of an administrative point of view.

Abstract

Drugs mostly represent an efficacy or an adverse effect according to their dosage and/or plasma concentrations. Therefore,to investigate the pharmacokinetic behavior of drugs including herbal medicines is necessary both to maximize the drug action and to minimize the adverse effect. To date, pharmacokinetic studies of herbal medicines have been conducted by some experts in this field on the bases of science and knowledge in Korea. On the other hand, in advanced countries, a typical series of pharmacokinetic studies has been conducted by using a harmonized guidance established. Consequently, an administrative support on these studies has to be needed in Korea as well. This study aimed to establish a draft guidance on pharmacokinetic studies of herbal medicines in non-clinical and clinical studies. Literatures previously published as well as guidances in the US, Europe and Japan were summarized for the present guidance. Effect of herbal medicines was listed on the proteins in charge of drug metabolism and transportation, as well as on the pharmacokinetics of chemical drugs. The present suggestion might be helpful to proceed pharmacokinetic studies of herbal medicines efficiently, and further polish should be needed in terms of an administrative point of view.

참고문헌 (58)

  1. 한대석, "생약학" (1988)
  2. "임상시험용 생약(한약)제제의 품질평가 가이드라인", 의약품본부 생약제제팀., ~ (2007)
  3. Guidance for Industry, "Botanical Drug Product FDA CDER", ~ (2004)
  4. 강원구, "SB-31의 Glycyrrhizin을 지표로 한 Rat과 Rabbit에서의 약물동태 및 심혈관계에 대한 효과 연구", 한국임상약학회지, 8(2), pp.122~132 (1998)
  5. Wang X, "Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates", Phytomedicine, 16(8), pp.712~725 (2009)
  6. Yin OQ, "Pharmacogenetics and herb-drug interactions: experience with Ginko biloba and omeprazole", Pharmacogenetics, 14(12), pp.841~850 (2004)
  7. Fan L, "Effect of Schizandra chinensis extract and Ginko biloba extract on the pharmacokinetics of talinolol in healthy volunteers", Xenobiotica, 39(3), pp.249~254 (2009)
  8. Tang J, "Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats", Phytotherapy Research, 23(5), pp.603~607 (2009)
  9. Fan L, "Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation", Eur J Clin Pharmacol, 65(4), pp.403~409 (2009)
  10. Li YH, "Effect of Danggui and Honghua on cytochrome P450 1A2, 2C11, 2E1 and 3A1 mRNA expression in liver of rats", Am J Chin Med, 36(6), pp.1071~1081 (2008)
  11. Seo KA, "The monoterpenoids cital and geraniol are moderate inhibitors of CYP2B6 hydroxylase activity", Chem Biol Interact, 174(3), pp.141~146 (2008)
  12. Di YM, "Clinical drugs that interact with St. John's wort and implication in drug development", Curr Pharm Des, 14, pp.1723~1742 (2008)
  13. Yoshida N, "Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport", Drug Metab Dispos, 36(7), pp.1206~1211 (2008)
  14. Tang H, "Evaluation of protective effects of Chi-Zhi-Huang decoction on phase I drug metabolism of liver injured rats by cocktail probe drugs", J Ethnopharmacol, 117(3), pp.420~426 (2008)
  15. Kim H, "Identification and characterization of potent CYP2B6 inhibitors in Woohwang cheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China", Drug Metab Dispos, 36(6), pp.1010~1015 (2008)
  16. Van der Bout-van den Beukel CJ, "Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections", Basic Clin Pharmacol Toxicol, 102(6), pp.515~26 (2008)
  17. Hellum BH, "In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products", Basic Clin Pharmacol Toxicol, 102(5), pp.466~475 (2008)
  18. Lee LS, "Possible differential induction of phase 2 enzyme and antioxidant pathways by American ginseng, Panax quinquefolius", J Clin Pharmacol, 48(5), pp.599~609 (2008)
  19. Zhang DM, "In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier", J Pharm Pharmacol, 59(12), pp.1733~1738 (2007)
  20. Fan L, "Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole", Acta Pharmacol Sin, 28(10), pp.1685~1692 (2007)
  21. Fan L, "The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1", Clin Pharmacol Ther, 83(3), pp.471~476 (2008)
  22. Hebert MF, "Effects of St John's wort (Hypericum perforatum) on tacrolimus pharmacok inetics in healthy volunteers", J Clin Pharmacol, 44(1), pp.89~94 (2004)
  23. Piscitelli SC, "Indinavir concentrations and St. John's wort", Lancet, 355(9203), pp.547~548 (2000)
  24. Zhou SF, "An update on clinocal drug interactions with the herbal antidepressant St. John's wort", Curr Drug Metab, 9(5), pp.394~409 (2008)
  25. Makino T, "Does a Kampo Medicine Containing Schisandra Fruit Affect Pharmacok inetics of Nifedipine Like Grapefruit Juice", Biol Pharm Bull, 29(10), pp.2065~2069 (2006)
  26. Bailey DG, "Interaction of citrus juices with felodipine and nifedipine", Lancet, 337(8736), pp.268~269 (1991)
  27. Ueng YF, "Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats", J Pharm Pharmacol, 57(2), pp.227~232 (2005)
  28. Gorski JC, "The effect of echinacea (Echinacea purpurea root) n cytochrome P450 activity in vivo", Clin Pharmacol Ther, 75(1), pp.89~100 (2004)
  29. Guo LQ, "Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity", Jpn J Pharmacol, 82(2), pp.122~9 (2000)
  30. Chang JC, "Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats", Chem Biol Interact, 182(2), pp.227~232 (2009)
  31. Ren YY, "Effects of ranitidine on pharmacokinetics of rhein from Dachengqi decoction in rats after oral administration", Zhong Xi Yi Jie He Xue Bao, 7(9월), pp.868~872 (2009)
  32. Ohinishi M, "Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline", Biol Pharm Bull, 32(6), pp.1080~1084 (2009)
  33. Cassileth BR, "Safety and pharma cokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients", Cancer Chemother Pharmacol, 65(1), pp.67~71 (2009)
  34. Fan L, "Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinease volunteers", Ann Pharmacother, 43(5), pp.944~949 (2009)
  35. Mu Y, "Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate PXR and increase warfarin clearance in rats", J Pharmacol Exp Ther, 316(3), pp.1369~1377 (2006)
  36. Moon A, "Effect of Glycyrrhiza glabra roots and glycyrrizin on the glucoronidation in rats", Planta Med, 63(2), pp.115~119 (1996)
  37. Chen MF, "Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone", Endocrinol Jpn, 38(2), pp.167~174 (1991)
  38. Teelucksingh S, "Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid", Lancet, 335(8697), pp.1060~1063 (1990)
  39. Bernardi M, "Effects of prolonged ingestion of graded doses of licorice by healthy volunteers", Life Sci, 55(11), pp.863~872 (1994)
  40. De Klerk GJ, "Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum", Br Med J, 314(7082), pp.731~732 (1997)
  41. Tang WF, "Effect of Da-Cheng-qi decoction on the pharmacokinetics of ranitidine in rats", Biomed chromatography, 22(8), pp.851~856 (2008)
  42. Johne A, "Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum)", Clin Pharmacol Ther, 66(4), pp.338~345 (1999)
  43. Bauer S, "Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients", Br J Clin Pharmacol, 55(2), pp.203~211 (2003)
  44. Hall SD, "The interaction between St John's wort and an oral contraceptive", Clin Pharmacol Ther, 74(6), pp.525~535 (2003)
  45. Wang Z, "Effect of St John's wort on the pharmacokinetics of fexofenadine", Clin Pharmacol Ther, 71(6), pp.414~420 (2002)
  46. Chiang HM, "Ginger significantly decreased the oral bioavailability of cyclosporine in rats", Am J Chin Med, 34(5), pp.845~855 (2006)
  47. Tsai TH, "Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats", Planta Med, 71(78), pp.640~645 (2005)
  48. Makino T, "Pharmacokinetic interactions between Japanese traditional Kampo medicine and modern medicine (IV). Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats", Biol Pharm Bull, 28(2), pp.280~284 (2005)
  49. Thabrew MI, "Effects of Cassia auriculata and Cardospermum halicacabum teas on the steady state blood levels of theophylline in rats", Drug Metabol Drug Interact, 20(4), pp.263~272 (2004)
  50. Thabrew I, "The effects of Cassia auriculata and Cardiospermum halicacabum teas on the steady state blood level and toxicity of carbamazepine", J Ethnopharmacol, 90(1), pp.145~50 (2004)
  51. Yuan CS, "Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial", Ann Intern Med, 141(1), pp.23~7 (2004)
  52. Buckley MS, "Fish oil interaction with warfarin", Ann Pharmacother, 38(10), pp.50~52 (2004)
  53. Efferth T, "Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells", Blood Cells Mol Dis, 28(2), pp.160~168 (2002)
  54. Zhu M, "Influence of Sanguisorba officinalis, a mineral-rich plant drug, on the pharma cokinetics of ciprofloxacin in the rat", 44(1), pp.125~128 (1999)
  55. Kim YS, "The effect of diphenyl-dimethyl-dicarboxylate on cyclosporine-A blood level in kidney transplants with chronic hepatitis", Korean J Intern Med, 12(1), pp.67~69 (1997)
  56. Piscitelli SC, "The effect of garlic supplements on the pharmacokinetics of saquinavir", Clin Infect Dis, 34(2), pp.234~238 (2002)
  57. Gallicano K, "Effect of short-term administration of garlic supplements on single dose ritonavir pharmacokinetics in healthy volunteers", Br J Clin Pharmacol, 55(2), pp.199~202 (2003)
  58. Bano G, "Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers", Eur J Clin Pharmacol, 41(6), pp.615~617 (1991)

관련 논문AI추천

이 간행물의 다른 논문 (8건)